Recent Articles & Documents
Intoxicated Donors and Heart Transplant Outcomes: Long-Term Safety
David A. Baran, M.D. System Director for Advanced Heart Failure and Transplantation at Sentara Heart Hospital in Virginia, publishes the first study that looks at donor toxicology records for heart transplant recipients.
David A. Baran, MD, contributes to this published paper that proposes criteria to define acute myocardial infarction complicated by cardiogenic shock (AMICS).
Sentara Healthcare begins in-house COVID-19 testing
Sentara Healthcare is now processing COVID-19 tests at a newly-created laboratory in Sentara Norfolk General Hospital
Colon Cancer Survivor Now Leading Health Equity Program at Sentara Healthcare
Colon cancer is one of many health disparities recognized in Hampton Roads
Is Less More When Treating Patients with Radiation Therapy?
Treatment for head and neck cancers usually involves high doses of radiation given over multiple sessions. Researchers at Sentara Healthcare investigate new methods of reducing radiation doses to patients with head and neck cancers by ...
Complex Mandibular Reconstruction: A Sentara Specialty
Mandibular reconstruction restores both mandible structure and function after the removal of cancerous bone. Surgeons use a fibula free flap, harvested from the patient’s own leg, to create replacement tissue for the new mandible.
Flex® Robotic System: A New Tool for Treating Head and Neck Cancer
The Flex® Robotic System offers surgeons an innovative new tool in the treatment of certain head and neck cancers. Unlike other robotic systems or therapies, the Flex® Robotic System works with a patient’s anatomy to deliver precise, effective ...
Head and neck cancers account for almost 4 percent of all cancers occurring within the United States. Providers at the Sentara EVMS Comprehensive Head and Neck Center pioneer cutting-edge research into managing such cancers.
New Therapies for Mitral Valve Regurgitation
Sentara’s physicians are taking part in first-of-their-kind studies to investigate new devices and surgical techniques as treatment options for mitral regurgitation.
New Watchman Device, Delivery System Prevents Blood Clots
A new clinical trial examines updates to the Watchman device, delivery system and surgical technique.
TAVR and Early TAVR in Low-Risk, Asymptomatic Patients
Two new clinical trials at Sentara Cardiovascular Research Institute investigate the TAVR procedure’s uses in low-risk and asymptomatic individuals.
Is the Cognitive Cardiologist Obsolete?
Current practice conditions are creating an existential threat for the cognitive cardiologist, and the resulting anxiety is contributing to physician burnout.
TAVR: Who’s the wrong candidate?
With the growing capabilities of TAVR, Paul D. Mahoney, MD, said, the concept of recommending a patient for TAVR over SAVR based on perceived surgical risk is almost obsolete.
Troponin Testing for Clinicians
This paper provides further explanation that will assist clinicians in their clinical decision making and interpretation of troponin test results.